Efficacy and Safety of Actovegin in Post-stroke Cognitive Impairment (PSCI)

NCT01582854 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

503

Enrollment

INDUSTRY

Sponsor class

Conditions

Post-Stroke Cognitive Impairment (PSCI)

Interventions

DRUG: Actovegin
DRUG: Placebo

Sponsor

Takeda